Nxera Pharma Co., Ltd. Share Price OTC Markets

Equities

SOLTF

JP3431300007

Pharmaceuticals

Market Closed - OTC Markets 17:20:04 20/06/2024 BST 5-day change 1st Jan Change
9.43 USD -5.70% Intraday chart for Nxera Pharma Co., Ltd. -.--% -5.70%

Financials

Sales 2024 * 36.59B 227M 17.92B Sales 2025 * 39.05B 242M 19.12B Capitalization 141B 873M 69.01B
Net income 2024 * -852M -5.27M -417M Net income 2025 * 2.54B 15.71M 1.24B EV / Sales 2024 * 4.33 x
Net Debt 2024 * 17.38B 108M 8.51B Net cash position 2025 * 14.05B 87.01M 6.88B EV / Sales 2025 * 3.25 x
P/E ratio 2024 *
60.5 x
P/E ratio 2025 *
26.6 x
Employees 350
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.88%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Nxera Pharma Co., Ltd.

1 day-5.70%
1 month+6.31%
3 months-10.41%
6 months-5.70%
Current year-5.70%
More quotes
1 month
9.36
Extreme 9.36
10.00
Current year
8.56
Extreme 8.56
13.43
1 year
8.56
Extreme 8.56
13.52
3 years
8.44
Extreme 8.44
22.78
5 years
8.44
Extreme 8.44
23.58
10 years
8.03
Extreme 8.03
237.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 19/09/17
Founder 74 21/06/90
Director of Finance/CFO - 23/03/22
Members of the board TitleAgeSince
Founder 74 21/06/90
Director/Board Member 66 26/03/19
Director/Board Member 59 24/03/20
More insiders
Nxera Pharma Co Ltd, formerly known as Sosei Group Corp, is a Japan-based company engaged in the biopharmaceutical business that handles from drug research (drug discovery) to development and sale. The Company is mainly engaged in the pharmaceutical business. The Company is engaged in drug discovery, translational medicine, preclinical and early clinical development, as well as the research and development, import/export, packaging, and sale of pharmaceuticals. The Company also conducts structural analysis of G protein-coupled receptors (GPCRs), creates initial lead compounds, and searches for candidate products using StaR technology.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1,568 JPY
Average target price
2,111 JPY
Spread / Average Target
+34.64%
Consensus